U.S., Oct. 22 -- An application to own the trademark for 'CYTOTIL15' has been filed on Apr. 17, 2025.
Owner(s):
Obsidian Therapeutics, Inc.; 1030 Massachusetts Avenue, Suite 400, MASSACHUSETTS
Goods and/or Services:
For: Cells for medical or clinical use; Pharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, and immunotherapy for the prevention and treatment of cancer, cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders; Biological preparations for the treatment of cancer.
Class(es): 005, 006, 0...